Aprea Therapeutics, Inc. (APRE)
0.695
-0.03
(-3.94%)
USD |
NASDAQ |
Oct 02, 16:00
0.6951
0.00 (0.00%)
After-Hours: 20:00
Aprea Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | -74.41K% |
| September 30, 2025 | -165.1K% |
| June 30, 2025 | -2.74K% |
| March 31, 2025 | -2.42K% |
| December 31, 2024 | -1.41K% |
| September 30, 2024 | -1.07K% |
| Date | Value |
|---|---|
| June 30, 2024 | -617.9% |
| March 31, 2024 | -738.3% |
| December 31, 2023 | -24.42K% |
| September 30, 2023 | -1.00K% |
| June 30, 2023 | -1.31K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Zymeworks, Inc. | -980.8% |
| Rhythm Pharmaceuticals, Inc. | -69.19% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -50.87% |
| Return on Assets | -44.60% |
| Return on Invested Capital | -50.87% |
| Return on Net Operating Assets | -19.59K% |